DeepMed Research

LIEBEL-FLARSHEIM COMPANY LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function

Phase 1

Completed

Conditions: Renal Insufficiency
Healthy Volunteers

Interventions: Drug: P03277

First Posted Date: 2018-09-05

Last Posted Date: 2019-10-22

Lead Sponsor: Guerbet

Target Recruit Count: 40

Registration Number: NCT03657784

Locations: 🇲🇩
Republican Clinical Hospital, Arensia EM Unit, Chisinau, Moldova, Republic of
🇷🇴
Arensia Phase I unit "Carol Davila" Nephrology Hospital, Bucharest, Romania

Cardiac Safety Evaluation of P03277

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: P03277 0.1 mmol/kg
Drug: Moxifloxacin 400mg
Drug: NaCl 0.9%
Drug: P03277 0.3 mmol/kg

First Posted Date: 2018-09-05

Last Posted Date: 2022-07-18

Lead Sponsor: Guerbet

Target Recruit Count: 48

Registration Number: NCT03657264

Locations: 🇧🇪
Clinical Pharmacology unit, SGS-Life Science Service, Antwerpen, Belgium

Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions

Phase 1

Completed

Conditions: Healthy Volunteers
Brain Lesion

Interventions: Drug: P03277
Drug: Placebo

First Posted Date: 2018-07-27

Last Posted Date: 2021-05-14

Lead Sponsor: Guerbet

Target Recruit Count: 142

Registration Number: NCT03603106

Locations: 🇧🇪
Clinical Pharmacology unit, SGS Life Science Services, Antwerpen, Belgium

Post-marketing Surveillance Study for Evaluation of Dotarem Safety

Completed

Conditions: Contrast-enhanced MRI With Dotarem

Interventions: Procedure: MRI with Dotarem

First Posted Date: 2017-02-09

Last Posted Date: 2017-05-02

Lead Sponsor: Guerbet

Target Recruit Count: 44456

Registration Number: NCT03048006

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

Completed

Conditions: MR Mammography With Dotarem

Interventions: Procedure: MR mammography with Dotarem

First Posted Date: 2017-02-02

Last Posted Date: 2017-05-02

Lead Sponsor: Guerbet

Target Recruit Count: 1537

Registration Number: NCT03041298

Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis

Phase 2

Completed

Conditions: HepatoCellular Carcinoma
Chronic Liver Disease

Interventions: Drug: P03277 at 0.1 mmol/kg
Drug: P03277 at 0.05 mmol/kg

First Posted Date: 2016-11-25

Last Posted Date: 2021-10-26

Lead Sponsor: Guerbet

Target Recruit Count: 41

Registration Number: NCT02973516

Locations: 🇫🇷
CHU Angers, Angers, France
🇫🇷
Hôpital Beaujon, Clichy, France

P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)

Phase 2

Completed

Conditions: CNS Lesion
Blood Brain Barrier Defect

Interventions: Drug: P03277
Drug: Gadobenate dimeglumine
Device: MRI

First Posted Date: 2015-12-17

Last Posted Date: 2021-10-25

Lead Sponsor: Guerbet

Target Recruit Count: 312

Registration Number: NCT02633501

Locations: 🇮🇹
Ospedali Riuniti di Ancona, Ancona, Italy
🇮🇹
AO S. Andrea Universita La Sapienza, Roma, Italy
🇭🇺
Pecsi Tudomany Egyetem Klinikai kozpont Idegsebeszeti Klinica, Pécs, Hungary

and more 25 locations

Evaluation of Lipiodol® Ultra Fluid in Association With Surgical Glues During Vascular Embolization.

Phase 4

Conditions: Angiosarcoma
Arteriovenous Malformation
Hemangioendothelioma
Congenital Hemangioma

Interventions: Drug: Lipiodol® Ultra Fluid with surgical glues

First Posted Date: 2015-12-09

Last Posted Date: 2020-02-19

Lead Sponsor: Guerbet

Target Recruit Count: 125

Registration Number: NCT02625389

Locations: 🇮🇳
Division of Peripheral Vascular & Endovascular sciences, Medanta-The Medicity Hospital, Gurgaon, Haryana, India
🇮🇳
Christian Medical College Hospital, Vellore, Tamil Nadu, India

DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years

Phase 4

Completed

Conditions: Magnetic Resonance Imaging

Interventions: Drug: DOTAREM

First Posted Date: 2015-04-08

Last Posted Date: 2017-03-09

Lead Sponsor: Guerbet

Target Recruit Count: 51

Registration Number: NCT02411201

Locations: 🇫🇷
CHU, Bordeaux, France
🇵🇱
Uniwersytecki Szpital Dziecięcy w Lublinie, Lublin, Poland
🇫🇷
Hôpital de Hautepierre, Strasbourg, France

and more 6 locations

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors

Phase 4

Completed

Conditions: Primary Brain Tumor

Interventions: Drug: Dotarem®
Drug: Gadovist®/Gadavist®

First Posted Date: 2014-01-13

Last Posted Date: 2016-12-30

Lead Sponsor: Guerbet

Target Recruit Count: 279

Registration Number: NCT02034708

Locations: 🇺🇸
UVM MRI Center for Biomedical Imaging, Burlington, Vermont, United States
🇺🇸
University of Arizona Medical Center, Tucson, Arizona, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

and more 29 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy